资讯

Many different types of oral antibiotics were used and the duration of treatment varied a lot between the studies. It is unclear whether antibiotics have any effect on hearing, as the evidence was not ...
William Brogan, 47, from Hamilton, South Lanarkshire, believes that if doctors had taken his symptoms more seriously the ...
Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...
THE  bad news is that chronic gum disease, also called chronic periodontitis, cannot be cured, although most of the symptoms may disappear for months after ...
Taurolodine locks are recommended for preventing CLABSI, but no data is available in regards using it for treatment: In this setting, it was efficient, as was ethanol. However, the bacteria used in ...
9. Gingivitis Current Treatment and Medical Practices 10. Unmet Needs 11. Gingivitis Emerging Therapies 12. Gingivitis Market Outlook 13. Country-Wise Gingivitis Market Analysis (2018–2030) 14.
OBJECTIVES: This study evaluated the resistance to antimicrobials of aerobes and facultative anaerobes isolated from patients wearing complete dentures, patients with gingivitis and periodontitis, and ...
Introduction The optimal duration of antibiotic therapy in children with febrile urinary tract infections (UTIs) is still a matter of debate. Current guidelines recommend treating children with ...
Prolonged symptom duration following delayed antibiotic prescription was reported by Little et al. (2009). [23] However, none of these studies involved a symptomatic treatment arm.
The analysis included studies published between May 2022 and November 2024. Study patients were allocated to 7 or 14 days of antibiotic therapy, and the primary outcome was 90-day all-cause mortality.
Antibiotics are supposed to wipe out bacteria, yet the drugs can sometimes hand microbes an unexpected advantage. A new study from Rutgers Health shows that ciprofloxacin, a staple treatment for ...
Fidaxomicin: A New Macrocyclic, RNA Polymerase-inhibiting Antibiotic for the Treatment of Clostridium difficile Infections Ian R Poxton Disclosures Future Virology. 2010;5 (4):539-548.